Eli Lilly & Co. (LLY) Unit to Acquire Rabies Vaccine Portfolio from Boehringer Ingelheim
Tweet Send to a Friend
Boehringer Ingelheim Vetmedica Inc. (BIVI) announced an agreement with Elanco U.S., Inc., a subsidiary of Eli Lilly and Company (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
